Brief: Cipla Q3 Consol Net Profit 6.76 Billion Rupees
23/01/2026 08:00
Jan 23 (Reuters) - Cipla Ltd CIPL.NS: Q3 CONSOL NET PROFIT 6.76 BILLION RUPEES; IBES EST. 12.42 BILLION RUPEES Q3 CONSOL TOTAL REVENUE FROM OPERATIONS 70.74 BILLION RUPEES, IBES EST. 74.76 BILLION RUPEES Source text: [ID:] Further company coverage: CIPL.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Cipla
See all newsFactbox: Global healthcare companies invest billions to boost US presence
Brief: Cipla, Qilu Pharmaceutical Partner For Licensing, Supply Of Biosimilar To Keytruda In US
India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar
Brief: Cipla Enters Exclusive Partnership With Qilu For Keytruda Biosimilar In US
Brief: Cipla and SBP Group Sign Exclusive Licensing Agreement For HER2 Bispecific Antibody-Drug Conjugate